Cytometry Part A

该期刊认为人工智能生成内容工具（如ChatGPT、Claude、Gemini等基于大语言模型的工具）不能在没有人类作者指导的情况下发起原创研究，也无法对已发表的工作或研究设计负责，也不具备法律地位或持有、转让版权的能力，因此根据COPE关于AI工具的立场声明，这些工具不能承担作者角色，也不能被列为作者。 模型中文摘要

Artificial Intelligence Generated Content (AIGC) tools—such as ChatGPT, Claude, Gemini, and others based on large language models (LLMs)—cannot be considered capable of initiating an original piece of research without direction by human authors. They also cannot be accountable for published work or research design, a generally held requirement of authorship (as discussed in the other sections), no…

所有列名作者应实质性参与稿件工作并同意最终提交版本，且该期刊对所有文章强制要求使用CRediT（贡献者角色分类法）。 模型中文摘要

All listed authors should have contributed to the manuscript substantially and have agreed to the final submitted version. Review editorial standards for a description of authorship criteria. For all articles, this journal mandates the CRediT (Contribution Roles Taxonomy)—more information is available on our Author Services site.

所有作者必须披露任何潜在利益冲突，包括可能影响研究的财务关系、专利或隶属关系；如无冲突，须明确声明。 模型中文摘要

All authors must disclose any potential conflicts of interest. This includes financial relationships, patents, or affiliations that could bias the study. If no conflicts exist, explicitly state this.

Cytometry Part A要求作者按照Wiley数据共享政策共享研究底层数据，并在投稿时选择合适的数据可用性声明；由于FlowRepository.org目前无法接受新数据存储，作者应将数据存入可靠且适合该领域的存储库。 模型中文摘要

Cytometry Part A requires authors to share the data underlying their research in accordance with Wiley’s Data Sharing Policy. Authors must select an appropriate data availability statement at submission. Data sharing supports transparency, reproducibility, and the advancement of scientific knowledge. Please note that FlowRepository.org is currently unavailable for new data deposits. If the resourc…

该期刊使用iThenticate的CrossCheck软件识别投稿稿件中重叠或相似的文本，以确保原创性并遵守伦理标准。 模型中文摘要

This journal utilizes iThenticate’s CrossCheck software to identify overlapping or similar text in submitted manuscripts, ensuring originality and adherence to ethical standards.

如引用第三方版权作品摘录，须在稿件中注明出处，作者须获得版权所有者的书面复制许可，通讯作者负责获得"印刷及其他媒体"复制许可并在投稿时提供给Wiley。 模型中文摘要

If excerpts from copyrighted works owned by third parties are included, credit must be shown in the contribution. It is your responsibility to also obtain written permission for reproduction from the copyright owners. For more information visit Wiley’s Obtaining Permission to Reproduce Material. The corresponding author is responsible for obtaining written permission to reproduce the material "in …

该期刊为订阅型出版物，提供开放获取选项，作者可在文章被接受后选择开放获取，需支付APC（除非适用豁免）。 模型中文摘要

This journal is a subscription-based publication that offers an Open Access option. You’ll have the option to make your article open access after acceptance, subject to an APC unless a waiver applies. Read more about APCs here.

稿件须经过由副主编主导、至少两名独立审稿人支持的严格同行评审，评审依据包括与期刊范围的相关性、对领域的影响、原创性、清晰度、方法可重复性、统计严谨性、伦理合规、与现有文献的整合以及文档和视觉呈现质量等标准。 模型中文摘要

Manuscripts are subject to a rigorous peer review process led by associate editors and supported by at least two independent reviewers. This thorough evaluation is guided by a comprehensive set of criteria designed to uphold the journal’s standards for high-quality and impactful publications. Submissions are assessed based on the following guidelines: Relevance to the journal’s scope. The manuscri…

该期刊使用iThenticate的CrossCheck软件识别投稿稿件中重叠或相似的文本以确保原创性和伦理合规，作者应查阅Wiley的出版伦理最佳实践，涉及人类或动物受试者的研究须在方法部分包含伦理批准声明，并遵守《赫尔辛基宣言》及相关机构/国家指南。 模型中文摘要

This journal utilizes iThenticate’s CrossCheck software to identify overlapping or similar text in submitted manuscripts, ensuring originality and adherence to ethical standards. Authors are encouraged to review Wiley’s Top 10 Publishing Ethics Tips for Authors and Wiley’s Publication Ethics Guidelines to familiarize themselves with best practices in publishing ethics. For studies involving human …

Cytometry Part A接受曾以预印本形式发布的文章进行评审，作者也可随时将投稿版本发布至预印本服务器，但须在预印本中更新指向最终发表文章的链接。 模型中文摘要

Cytometry Part A will consider for review articles previously available as preprints. You may also post the submitted version of a manuscript to a preprint server at any time. You are requested to update any pre-publication versions with a link to the final published article.